NORDIC BIOSCIENCE HOLDING A/S
NORDIC BIOSCIENCE HOLDING A/S is a Danish holding company with consolidated accounts, headquartered in Hellerup, Denmark. The available filing excerpt does not disclose the operating business of the group, so the company can only be identified here as a corporate holding structure rather than a specific operating product company.
Fiscal year 2025 · change from previous year
Development 2023–2025
Business
Share of revenueCorporate ownership, governance, and oversight of consolidated subsidiaries.
Customers
The available information does not identify external customer segments or end markets for the group. As a holding company, its value is likely derived from ownership and oversight of subsidiaries rather than direct sales to customers.
The holding company’s economic exposure is to its controlled group companies and their underlying businesses.
Geography
The company is based in Denmark, with its registered address in Hellerup. No revenue geography, operating country, or international market breakdown is disclosed in the provided material, so the business footprint cannot be reliably mapped beyond the Danish parent entity.
Risks
The main identifiable risk is information risk: the provided material does not disclose the operating business, revenue base, or customer exposure of the group. As a holding structure, the company would also be exposed to subsidiary performance, valuation uncertainty, and dependence on the value of its investments, but the excerpt does not provide enough detail to quantify those risks.
- Subsidiary valuation and impairmentImpact: HighLikelihood: Medium
A holding company depends on the carrying value of investments, which can be sensitive to underlying performance and fair value assumptions.
Exposure: Investment portfolio
- Undisclosed operating businessImpact: MediumLikelihood: High
The filing excerpt does not identify what the group actually sells or where it operates, limiting investor visibility.
Exposure: Corporate disclosure quality
Accounting
Judgemental itemsReported results depend on which subsidiaries are consolidated and how intra-group balances are eliminated.
Impact: Affects balance sheet and group-level equity
Holding companies often carry investments at cost or fair value, requiring judgment on recoverability.
Impact: Can materially affect profit and equity
The filing references reserves of exchange differences on translation, which can affect equity volatility.
Impact: Impacts other comprehensive income and equity
Similar listed companies
Publicly listed companies with a comparable business focus.
Nordicus Partners Corp
NORD · Services-Management Consulting Services
Nordicus Partners Corp is a U.S.-listed business accelerator and holding company focused on Nordic life sciences ventures.
Novo Nordisk A/S
NVO · Pharmaceutical Preparations
Novo Nordisk A/S is a Denmark-based pharmaceutical company focused on medicines for diabetes, obesity, and other serious chronic diseases.
Bone Biologics Corp
BBLG · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Bone Biologics Corp is a U.S.-based clinical-stage medical device company focused on bone regeneration for spinal fusion procedures.
Nautilus Biotechnology, Inc.
NAUT · Laboratory Analytical Instruments
Abpro Holdings, Inc.
ABPO · Biological Products, (No Diagnostic Substances)
Alector, Inc.
ALEC · Biological Products, (No Diagnostic Substances)
Last updated: 24/10/2026